AkzoNobel to Issue €800 Million Bond

AkzoNobel said it intends to issue a €800 million bond with a seven year maturity, at a coupon of 4%. The announcement of the bond was well received by the market with an order book exceeding €3 billion.

AkzoNobel has simultaneously announced a tender offer to re-purchase an estimated €600 million of its previously issued bonds, specifically bonds set to mature in January 2014 (7.75%, €1 billion) and March 2015 (7.25%, €975 million).

The new bond issue and purchase of existing bonds will improve the overall debt profile of AkzoNobel, further reducing future refinancing risk and improving its maturity profile.

The buyback of company bonds will result in an accounting loss, which will be determined at the end of the tender process. However, this loss will be off-set by the significantly reduced coupon on the new seven year bond.

The new bonds will be issued by Akzo Nobel NV and will be listed on the Luxembourg Stock Exchange. Settlement is scheduled for Dec. 15, 2011, and the bonds will mature on Dec.17, 2018.

AkzoNobel said it is committed to maintaining a strong investment grade rating. Currently the company has a BBB+ rating with Standard & Poor's and a Baa1 rating with Moody's.

 

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.